Sign up for Enews

Enter your e-mail address to receive our free monthly e-newsletter.

Ascendant Diagnostics | Tear-Based Breast Cancer Diagnosis

Ascendant Dx

Ascendant Dx is an early stage biotechnology company that was formed in September of 2010 with a focus on developing innovative new approaches to improve the diagnosis of serious disease and conditions.

Ascendant’s first product in development is an in vitro diagnostic assay to detect early stage breast cancer utilizing the proteomic profile present in tears. Implementation of our test in the market place will lead to greater rates of survivability by increasing early detection of breast cancer.

We believe our simple, non-invasive tear-based collection method will rapidly lead to increased participation by individuals who choose not to utilize currently available yearly screening methods. 


  • Life Sciences
  • Biotechnology

Contact Information

Management Team

  • Omid Moghadam,
  • Chief Executive Officer
  • Anna Daily, PhD
  • Senior Scientist
  • Kimberley Fuller,
  • Director of Market Research
  • and Business Development

Latest News

  • Innovate 2 Educate Event Allows Students to Solve Problems

    Students from eStem Public Charter High School in downtown Little Rock spent Friday morning pitching startup ideas devoted to applying a little innovation to the current educational model. About 200 students from the Noble Impact and EAST Initiative programs at eStem took part Friday morning in the inaugural Innovate 2 Educate (i2e) event, sponsored by Innovate Arkansas.

    Read More »

  • Video: ARK Challenge Concludes Fourth Run in Little Rock

    The ARK Challenge startup accelerator last week concluded its fourth installment, and first in Little Rock, with Demo Day presentations of company pitches held inside the Clinton Center's Great Hall.

    Read More »

  • Mid-America Science Museum Renovation on Schedule, Re-opening Set for March

    The museum closed in August to begin remodeling and adding exhibits and new features, thanks to a $7.8 million grant from the Donald W. Reynolds Foundation.

    Read More »

  • Pharmacy Firm RxResults Adding Jobs

    RxResults, a pharmacy risk management company that is partly owned by the University of Arkansas for Medical Sciences, said it plans to add between 20 and 30 jobs in the next 21 months, according to a UAMS news release. Founded in 2008, RxResults was created to help lower drug costs for employers and their workers while making sure they receive the best medicines available.

    Read More »